You may also explore our diagnostic services, review patient experiences on what our patients say, or learn more about CD22 markers from the National Cancer Institute.
\nDisclaimer: This information is provided for general awareness only and does not substitute professional medical advice. Test results must be interpreted by a qualified healthcare professional. Please refer to the disclaimer policy for complete details.
","image":["/images/healthcarentsickcarestore.shop/images/product/cd22-test-1.avif"],"sku":"cd22-test","brand":{"@type":"Brand","name":"healthcare nt sickcare"},"offers":{"@type":"AggregateOffer","lowPrice":2999,"highPrice":2999,"priceCurrency":"USD","availability":"https://schema.org/InStock","url":"https://healthcarentsickcarestore.shop/products/cd22-test","offerCount":1}}
CD22 Blood Test
CD22 Blood Test Overview
The CD22 test is a specialised immunophenotyping blood test used to detect and assess the expression of the CD22 marker on B-lymphocytes. CD22 plays an important role in B-cell regulation and signalling, and its evaluation is clinically significant in the assessment of certain lymphoid and immune-related disorders.
In Pune, Maharashtra, the CD22 test is commonly advised during the diagnosis or monitoring of B-cell lymphoproliferative disorders and selected blood cancers. The test requires a venous blood sample and can be availed through the Home Collection Facility or the Direct Walk-in Facility of healthcare nt sickcare. Patients may review general instructions beforehand via the test preparation guides.
Clinical Relevance of CD22 Testing
- Supports immunophenotyping of B-cell disorders
- Helps in diagnosis and classification of lymphoid malignancies
- Used for disease monitoring and treatment assessment
Test Details
Sample Type
Venous blood sample
Turnaround Time
Reports are generally available within 24 to 48 hours on the secure online portal.
Frequently Asked Questions
The CD22 test is recommended when doctors need to evaluate suspected B-cell lymphoproliferative disorders or perform detailed immunophenotyping during blood investigations.
Doctors advise this test to assess CD22 expression on B-lymphocytes, which helps in diagnosing, classifying, and monitoring specific lymphoid conditions.
Fasting is not required for the CD22 blood test. Patients should inform their doctor about ongoing medications or recent treatments before sample collection.
This test may be advised in cases of persistent lymph node swelling, unexplained fatigue, abnormal blood counts, or suspected B-cell malignancies. Related topics are discussed in our health articles section.
You may also explore our diagnostic services, review patient experiences on what our patients say, or learn more about CD22 markers from the National Cancer Institute.
Disclaimer: This information is provided for general awareness only and does not substitute professional medical advice. Test results must be interpreted by a qualified healthcare professional. Please refer to the disclaimer policy for complete details.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
CD22 Blood Test Overview
The CD22 test is a specialised immunophenotyping blood test used to detect and assess the expression of the CD22 marker on B-lymphocytes. CD22 plays an important role in B-cell regulation and signalling, and its evaluation is clinically significant in the assessment of certain lymphoid and immune-related disorders.
In Pune, Maharashtra, the CD22 test is commonly advised during the diagnosis or monitoring of B-cell lymphoproliferative disorders and selected blood cancers. The test requires a venous blood sample and can be availed through the Home Collection Facility or the Direct Walk-in Facility of healthcare nt sickcare. Patients may review general instructions beforehand via the test preparation guides.
Clinical Relevance of CD22 Testing
- Supports immunophenotyping of B-cell disorders
- Helps in diagnosis and classification of lymphoid malignancies
- Used for disease monitoring and treatment assessment
Test Details
Sample Type
Venous blood sample
Turnaround Time
Reports are generally available within 24 to 48 hours on the secure online portal.
Frequently Asked Questions
The CD22 test is recommended when doctors need to evaluate suspected B-cell lymphoproliferative disorders or perform detailed immunophenotyping during blood investigations.
Doctors advise this test to assess CD22 expression on B-lymphocytes, which helps in diagnosing, classifying, and monitoring specific lymphoid conditions.
Fasting is not required for the CD22 blood test. Patients should inform their doctor about ongoing medications or recent treatments before sample collection.
This test may be advised in cases of persistent lymph node swelling, unexplained fatigue, abnormal blood counts, or suspected B-cell malignancies. Related topics are discussed in our health articles section.
You may also explore our diagnostic services, review patient experiences on what our patients say, or learn more about CD22 markers from the National Cancer Institute.
Disclaimer: This information is provided for general awareness only and does not substitute professional medical advice. Test results must be interpreted by a qualified healthcare professional. Please refer to the disclaimer policy for complete details.
